Keywords: Pfizer, Wyeth, Class action, Securities fraud, Pristiq, USA

Pfizer to face class action over alleged securities fraud by Wyeth

Article | 19 September 2012

Print This

Global pharma behemoth Pfizer (NYSE: PFE) must face the music over allegations that Wyeth, a subsidiary if Pfizer since 2009, had ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in